Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as €42.81 ($45.06) and last traded at €41.97 ($44.18), with a volume of 341750 shares changing hands. The stock had previously closed at €43.00 ($45.26).
Fresenius Medical Care Price Performance
The company has a market capitalization of $12.48 billion, a price-to-earnings ratio of 23.19, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a quick ratio of 0.80, a current ratio of 1.46 and a debt-to-equity ratio of 77.56. The company has a 50 day simple moving average of €38.47 and a 200 day simple moving average of €37.37.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- Basic Materials Stocks Investing
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Read Stock Charts for Beginners
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 10 Best Airline Stocks to Buy
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
